Friday 6 November 2026 Export DHR’s income statement to Excel — free account

Danaher Corporation

DHR Healthcare Diagnostics & Research

Danaher Corporation’s revenue for fiscal 2025 (year ended December 2025) was $24.6 billion, up 2.90% from fiscal 2024.

Revenue: +8.28%
EPS: +36.7%
Free cash flow: +19.1%
Total debt: +44.9%

Quarter to September 2026, against a year earlier

S&P 500

227.41 1.07 +0.47%

Follow DHR

Alert me

Market cap: $159.2B
P/E: 37.0×
Fwd P/E: 36.9×
Dividend yield: 0.67%
F-score: 6/9
Altman Z: 4.52
Beneish M: −2.57
Dividend safety: 69/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Danaher Corporation (DHR) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, Danaher Corporation (DHR) trades at a price to free cash flow of 27.7×. Over the past ten years it has ranged from 11.4× (September 2015) to 40.7× (August 2024); the current reading is higher than 71% of that period. That is below the Diagnostics & Research industry median of 33.5× and above the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/DHR/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="Danaher Corporation price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/DHR/metrics/price-to-free-cash-flow">Danaher Corporation (DHR) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2025	30.8×	(2.48%)
FY2024	31.6×	5.88%
FY2023	29.9×	31.75%
FY2022	22.7×	(22.16%)
FY2021	29.1×	13.89%
FY2020	25.6×	(12.18%)
FY2019	29.1×	57.15%
FY2018	18.5×	(4.14%)
FY2017	19.3×	18.22%
FY2016	16.3×	25.57%

Period	Price to free cash flow	Change
Sep 2026	27.1×	10.78%
Jun 2026	24.5×	(3.02%)
Mar 2026	25.2×	(18.12%)
Dec 2025	30.8×	9.99%
43 more quarters	Free account

Against its own ten years

Low 11.4× High 40.7×

Ten-year median 24.0×

Current reading's percentile 71

Company	Price to free cash flow
IQV IQVIA Holdings Inc. compare	21.0×
DHR Danaher Corporation	27.7×
ILMN Illumina, Inc. compare	30.4×
TMO Thermo Fisher Scientific Inc. compare	32.9×
A Agilent Technologies, Inc. compare	38.2×
MTD Mettler-Toledo International, Inc. compare	39.1×
IDXX IDEXX Laboratories, Inc. compare	40.6×
WAT Waters Corporation compare	173×
NTRA Natera, Inc. compare	1,004×
Diagnostics & Research industry median	33.5×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

Danaher Corporation (DHR) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on DHR

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on DHR

Stockrow Weekly